TrialOncology research2017

Circulating Tumor Cells Predict Prognosis Following Tyrosine Kinase Inhibitor Treatment in EGFR-Mutant Non-Small Cell Lung Cancer Patients.

Baohong Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.